Gregor Nosan

Dr. Gregor Nosan

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 September 2022 in Croatian Medical Journal
Verified
Journal Article
Open access
SCSandra Cerar
Sandra Cerar
RKRok Kučan
Rok Kučan
DPDarja Paro-Panjan
Darja Paro-Panjan
GNGregor Nosan
Gregor Nosan
Aim To identify the epidemiological and clinical features of acute viral lower respiratory tract infections (LRTI) caused by respiratory syncytial virus and other respiratory virus-es, and to determine the risk factors for the severe disease among neonates.Methods We retrospectively reviewed the records of ne-onates aged up to 44 postconceptional weeks who were hospitalized at a tertiary referral hospital due to confirmed viral LRTI between January 2015 and December 2020.Results Of 228 neonates with viral LRTI, one-third were born prematurely. A seasonal distribution of LRTIs from December to March was noticed, peaking in February. For-ty-two percent of neonates were treated in the neonatal intensive care unit. One third of these presented with com-plications and needed mechanical ventilation. The most detected viruses were respiratory syncytial virus and rhi-novirus. Prematurity was identified as a risk factor for worse clinical course and more complications, while rhinovirus infection was associated with an increased risk of apnea.Conclusions The burden of respiratory syncytial virus LRTI in the neonatal period is high, although other respiratory viruses can also cause a severe respiratory disease. In pre -term infants, rhinovirus infection presents an important risk factor for a severe course of LRTI with complications. Infection with two respiratory viruses leads to a more se-vere clinical course.

29 December 2022 in The Pediatric Infectious Disease Journal
Verified
Journal Article
Closed access
HBHana Bešić
Hana Bešić
DPDarja Paro-Panjan
Darja Paro-Panjan
GNGregor Nosan
Gregor Nosan
Neonatal toxic shock syndrome (TSS)-like exanthematous disease is characterized by exanthema, thrombocytopenia and fever in neonates infected with TSS toxin-1 producing Staphylococcus aureus. Although the disease is rare, it should be known to neonatologists as it represents a differential diagnosis in neonates with exanthema and thrombocytopenia. Two presented neonates with Neonatal TSS-like exanthematous disease are rare European cases of this specific neonatal disease.

24 April 2024 in Central European Journal of Paediatrics
Verified
Journal Article
Open access
PDF file
GNGregor Nosan
Gregor Nosan
Objectives −To analyze the current umbilical cord (UC) care practice in Slovenia and to evaluate the impact of national UC care recommendations by comparing the UC care practice before and after their introduction.Materials and Methods − A questionnaire covering the complete UC care was sent to medical nurses and midwifes involved in UC care in primary-level pediatric centers, health visiting and parent education services (outpatient group) and secondary and tertiary-level pediatric centers (inpatient care group) in Slovenia. Three different clinical conditions of the newborn’s umbilicus, i.e. healthy umbilicus (HU), umbilicus at risk (RU) and unhealthy umbilicus (UU) were used. The inpatient and outpatient groups and UC care in 2013 and 2021 were compared.Results − The sample included 396 respondents from all Slovenian regions. The odds for using UC care protocol in 2021 were 2.6 times higher compared to 2013 (P<0.001). The UC care of HU changed: the dry UC care became less frequent (P<0,001), the use of normal saline solution increased and the use of ethanol solution decreased (P<0.001). The use of ethanol solution for UU decreased (P<0.001) and the use of octenidine increased more than 200 times (P<0.001). Conclusions − The implementation of national recommendations significantly influenced the UC care in Slovenia. The current UC care practice is more unified and consistent with international recommendations. The adjusted UC care, depending on the clinical condition of the newborn’s umbilicus, puts additional value to these recommendations. Further refinements of the UC care protocol should emphasize the use of dry UC care.

5 September 2024 in Life
Verified
Journal Article
Open access
PDF file
APAna Peterlin
Ana Peterlin
SBSara Bertok
Sara Bertok
KWKarin Writzl
Karin Writzl
LLLuca Lovrečić
Luca Lovrečić
AMAleš Maver
Aleš Maver
GNGregor Nosan
Gregor Nosan
Congenital heart disease (CHD) is the most commonly detected congenital anomaly and affects up to 1% of all live-born neonates. Current guidelines support the use of chromosomal microarray analysis (CMA) and next-generation sequencing (NGS) as diagnostic approaches to identify genetic causes. The aim of our study was to evaluate the diagnostic yield of CMA and NGS in a cohort of neonates with both isolated and syndromic CHD. The present study included 188 infants under 28 days of age with abnormal echocardiography findings hospitalized at the Department of Neonatology, UMC Ljubljana, between January 2014 and December 2023. Phenotypic data were obtained for each infant via retrospective medical chart review. We established the genetic diagnosis of 22 distinct syndromes in 17% (32/188) of neonates. The most frequent genetic diagnoses in diagnosed cases were 22q11.2 microdeletion and CHARGE syndromes, followed by Noonan syndrome and Williams syndrome. In addition, we detected variants of uncertain significance in 4.8% (9/188) of neonates. Timely genetic diagnosis is important for the detection of syndrome-related comorbidities, prognosis, reproductive genetic risks and, when appropriate, genetic testing of other family members.

4 September 2025 in Vaccine
Verified
Journal Article
Open access
GNGregor Nosan
Gregor Nosan
AŠAndreja Cerkvenik Škafar
Andreja Cerkvenik Škafar
Tuberculosis (TB) remains a global health challenge, with around 10 million new cases reported annually and multidrug-resistant strains complicating control efforts. Although incidence has declined in many high-income regions, neonatal populations remain vulnerable, underscoring the continued role of Bacillus Calmette-Guérin (BCG) vaccination. BCG vaccination provides strong protection against severe forms of TB in infancy, though its efficacy against pulmonary disease in adolescents and adults is modest. However, the BCG vaccine carries a risk of disseminated infection in immunocompromised newborns, emphasizing the importance of integrating immunodeficiency screening into vaccination strategies. Slovenia introduced universal newborn screening for inborn errors of immunity (IEI) in 2024 and, in 2025, revised its neonatal BCG vaccination protocol to incorporate screening results before vaccination. Under this approach, blood sampling occurs at ≥48 h, results are available by days 5-7, and BCG is administered between 7 and 14 days of life. This model balances timely TB protection with safety for at-risk infants. The Slovenian experience exemplifies a precision vaccination strategy that integrates real-time immunogenetic data with targeted BCG administration. This approach aligns with World Health Organization goals to modernize TB prevention while awaiting next-generation vaccines and may serve as a guide for other low-incidence countries.

30 June 2024 in Slovenian Medical Journal
Verified
Journal Article
Open access
PDF file
NENika Eržen
Nika Eržen
BKBojan Korpar
Bojan Korpar
MMMinca Mramor
Minca Mramor
SBSaba Battelino
Saba Battelino
ŠMŠpela Markelj
Špela Markelj
GNGregor Nosan
Gregor Nosan
Prirojena okužba s citomegalovirusom (pCMV) je v razvitih državah najpogostejša prirojena okužba ter najpogostejši vzrok za senzorinevralno okvaro sluha in razvojnonevrološke motnje. Le manjši delež otrok s pCMV ima ob rojstvu izražene znake bolezni, medtem ko je pri večjem deležu otrok s pCMV ob rojstvu okužba klinično nema. Vendar ti otroci lahko kljub temu dolgoročno razvijejo razvojnonevrološko motnjo. Zlasti so ogroženi za nastanek okvare sluha. Glede na evropske epidemiološke podatke in ocenjeno incidenco pCMV v Sloveniji, ki znaša 0,14 %, se pri nas rodi nezanemarljivo število otrok s pCMV. Danes odkrijemo le manjši delež novorojenčkov s pCMV, večinoma le tiste, ki imajo ob rojstvu tudi izražene znake bolezni. Dokler za to bolezen ni univerzalnega presejanja nosečnic in novorojenčkov na pCMV, je smiselno dosledno izvajati usmerjeno presejanje novorojenčkov ter z ustrezno obravnavo izboljšati dolgoročni razvojnonevrološki izid pri otrocih. V prispevku predstavljamo izhodišča za usmerjeno presejanje novorojenčkov na pCMV ter protokol obravnave otrok s pCMV.